Cutting Edge Health to improve neuromodulation therapies with new partnership
Interventional neuroscience service provider Cutting Edge Health has formed a partnership with the mental wellness app Limitless Guided Visualizations, aiming to augment patient outcomes during and between ketamine and neuromodulation therapies.
The collaboration introduces a blend of neurological treatments and guided mindset support, providing patients with tools to address complex health conditions such as pain and mood disturbance and bolster cognitive patterns.
Limitless founder Cali Wilson said: "[Cutting Edge Health CEO] Dr Landrum's dedication to incorporating metacognitive healing alongside medical interventions is a model for the future of integrative health.
"His forward-thinking approach shows patients they're not only receiving expert medical care but also gaining tools to nurture their inner resilience and long-term well-being."
Claimed to be one of the few clinics in the US Midwest to offer an integrated approach, Cutting Edge Health combines various therapies, including transcranial magnetic stimulation (TMS), intravenous (IV) ketamine therapy, and dual sympathetic reset (DSR).
Additionally, it provides at-home transcranial direct current stimulation (tDCS) as part of a remote maintenance programme.
To improve the therapies, Limitless Guided Visualizations are seamlessly integrated into both in-clinic and remote care settings.
Patients can achieve optimal brain states, enhancing the effectiveness of treatments and contributing to sustained results, stated the companies.
Landrum said: "We're learning how brain connections influence conditions like depression, anxiety, and PTSD and how activating these circuits can break negative cycles. Limitless Guided Visualizations empowers patients to strengthen these connections, reinforcing the positive effects of our interventions for better outcomes."
According to recent studies, combining medical interventions with metacognitive strategies can lead to reduced anxiety, increased patient engagement, and improved overall outcomes.
Limitless' app-based Journey Macrodoses and Mindset Microdoses aim to solidify the neural pathways formed by therapies such as ketamine, ensuring the longevity of each therapeutic breakthrough.
The key benefits for patients are claimed to include meaningful engagement through guided audio sessions that encourage active participation in their treatment.
The tailored soundscapes and mindfulness techniques offer calmer and more confident experiences, while the consistent use of these tools can strengthen neural pathways.
This support extends beyond the clinic, with daily mindset exercises and immersive guidance to help patients maintain their progress.
"Cutting Edge Health to improve neuromodulation therapies with new partnership" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19-05-2025
- Yahoo
Two Ukrainian veterans with amputations climbed the Himalayas
Two veterans of Defence Intelligence of Ukraine, both amputees, have conquered the Himalayas. The expedition included veterans Ivan Tarn from the Artan special operations forces unit and Oleksandr Dashko from the Kraken special operations forces unit. Source: Defence Intelligence of Ukraine Details: The soldiers were accompanied by professional climbers Tetiana Yalovchak and Taras Pozdnii. Together, they climbed to Everest Base Camp, located at an altitude of 5,280 metres. "You see all this in front of you, but it's hard to believe your eyes. It's like looking at a very, very real photo wallpaper. Incredible beauty," Ivan Tarn shared his impressions. Participation in the project was a serious challenge for the veterans. "Many people didn't believe in this project or in me because I have a very extensive amputation. No matter who I told about this adventure, they said: 'People with two legs can't even climb up there, and you don't have a leg; you'll ruin your health even more – don't go. It was challenging for me, but other guys with amputations need to see this climb. They need to see that there is life after amputation," emphasised Oleksandr Dashko. Oleksandr Dashko. Photo: Defence Intelligence of Ukraine on Facebook The expedition took place as part of the Limitless project, which aims to draw attention to the problems faced by amputees and raise 3 million UAH (about US$72,000) to combat phantom pain. "Until now, Ukrainians with amputations had never climbed this peak. This is more than just a track. It is proof that there are no limits for those who have a goal and the strength to keep going. Proof that life after amputation is possible. This climb is for everyone who is currently fighting, recovering and trying to live a full life despite everything," the project page says. Background: Earlier, there was the story of Ukrainian defender Roman "Dobriak" Kolesnyk, who lost his leg on the front line and went on a hike in the Carpathians on a prosthesis to raise funds for the military. Support Ukrainska Pravda on Patreon!
Yahoo
06-02-2025
- Yahoo
Cutting Edge Health to improve neuromodulation therapies with new partnership
Interventional neuroscience service provider Cutting Edge Health has formed a partnership with the mental wellness app Limitless Guided Visualizations, aiming to augment patient outcomes during and between ketamine and neuromodulation therapies. The collaboration introduces a blend of neurological treatments and guided mindset support, providing patients with tools to address complex health conditions such as pain and mood disturbance and bolster cognitive patterns. Limitless founder Cali Wilson said: "[Cutting Edge Health CEO] Dr Landrum's dedication to incorporating metacognitive healing alongside medical interventions is a model for the future of integrative health. "His forward-thinking approach shows patients they're not only receiving expert medical care but also gaining tools to nurture their inner resilience and long-term well-being." Claimed to be one of the few clinics in the US Midwest to offer an integrated approach, Cutting Edge Health combines various therapies, including transcranial magnetic stimulation (TMS), intravenous (IV) ketamine therapy, and dual sympathetic reset (DSR). Additionally, it provides at-home transcranial direct current stimulation (tDCS) as part of a remote maintenance programme. To improve the therapies, Limitless Guided Visualizations are seamlessly integrated into both in-clinic and remote care settings. Patients can achieve optimal brain states, enhancing the effectiveness of treatments and contributing to sustained results, stated the companies. Landrum said: "We're learning how brain connections influence conditions like depression, anxiety, and PTSD and how activating these circuits can break negative cycles. Limitless Guided Visualizations empowers patients to strengthen these connections, reinforcing the positive effects of our interventions for better outcomes." According to recent studies, combining medical interventions with metacognitive strategies can lead to reduced anxiety, increased patient engagement, and improved overall outcomes. Limitless' app-based Journey Macrodoses and Mindset Microdoses aim to solidify the neural pathways formed by therapies such as ketamine, ensuring the longevity of each therapeutic breakthrough. The key benefits for patients are claimed to include meaningful engagement through guided audio sessions that encourage active participation in their treatment. The tailored soundscapes and mindfulness techniques offer calmer and more confident experiences, while the consistent use of these tools can strengthen neural pathways. This support extends beyond the clinic, with daily mindset exercises and immersive guidance to help patients maintain their progress. "Cutting Edge Health to improve neuromodulation therapies with new partnership" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
24-01-2025
- Yahoo
Local health care provider weighs in on Rocephin concerns amid ADPH investigation
Jan. 24—The Alabama Department of Public Health is investigating some reports of adverse reactions to injections of the antibiotic ceftriaxone, or Rocephin, but a local health provider said she has seen no serious reactions to the drug in her practice. The ADPH on Tuesday issued a statement that it is reviewing 11 incidents of adverse reactions to the drug over the last few months and encouraged health care providers to discuss its use with patients and to "have a plan in place to respond to any adverse events." It also requested that providers report any adverse reactions to the drug. Nurse practitioner Crystal Landrum, who owns Riverside Family Health in Southeast Decatur, said she injects patients with Rocephin two to three times a week and has not witnessed any serious reactions. As recently as Monday, she administered three Rocephin shots to children with ear infections and had "no problems whatsoever." "I think the most I've ever had was a little redness in the leg and that was probably eight or nine months ago," Landrum said. Landrum said she typically gives Rocephin to patients with bad bacterial infections and it is mostly used in pediatric cases for ear infections and pneumonia. Teenagers receive the drug for sexually transmitted diseases. "Some of the cases reviewed have had signs and symptoms compatible with anaphylactic reaction, including hives, pruritis, hypotension, and hypoxia, which have been successfully treated with measures for anaphylaxis," according to ADPH. Anaphylaxis is a severe allergic reaction that must be treated immediately with an injection of epinephrine. Landrum said she believes anaphylactic reactions to Rocephin are rare, noting that in her 30 years in the medical field — including 18 years as an emergency room nurse — she has never witnessed a single case of anaphylaxis caused by the drug. "The way you classify the difference is, if they have a rash with it and I have to give a steroid, then that's not anaphylaxis," Landrum said. "But if they have a reaction to it and I have to put them in the hospital or I have to send them to the ER because the reaction is so bad, then that can be considered mild anaphylaxis." Landrum said 11 anaphylactic reactions in just a few months was unusual. Local and area hospitals say they are working closely with the ADPH and following their guidelines. North Alabama Medical Center in Florence issued a statement Tuesday saying it was removing Rocephin "out of an abundance of caution" despite no reactions having been reported in its facilities. Landrum said she does not understand why the hospital is removing the drug since there were no adverse reactions reported. "It seems a little overkill because ... the ADPH didn't tell us not to use it, they just said to make sure we were monitoring for allergic reactions and to report any allergic reactions," Landrum said. "Removing Rocephin from a hospital, I would say that's huge. That is every major infection, that's some pre-op surgery drugs, so I don't see the research behind that big of a decision." Landrum said there are substitute IV antibiotic drugs that health facilities can use in place of Rocephin if they do decide to remove it. The ADPH statement said it has found no causal link between Rocephin and the adverse reactions. Because of the absence of a causal link, Landrum said the problem may not be from the drug. "Rocephin comes in a powder, and you have to mix it, and you can either mix it with sodium chloride or lidocaine because the shot burns when you give it," Landrum said. "Depending on what they are mixing it with, the reaction can be with the lidocaine and not the Rocephin. Without having that information on those 11 anaphylaxes, those are some of the things they're going to have to look at; what it was mixed with, whether it was IV (intravenous) or IM (intramuscular), or if it was mixed with saline or lidocaine." — or 256-340-2442.
